KATHLEEN GUEST: Open Payments
NPI 1932650124 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,947 in 153 payments from 20 companies in 2025. Trend: 2023 $1,484 · 2024 $3,189 · 2025 $2,947
Food & beverage: $2,947
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $667 |
| Vanda Pharmaceuticals Inc. | 13 | $404 |
| Novartis Pharmaceuticals Corporation | 19 | $286 |
| Eisai Inc. | 16 | $246 |
| UCB, Inc. | 10 | $221 |
| PFIZER INC. | 11 | $179 |
| CATALYST PHARMACEUTICALS, INC. | 7 | $177 |
| Genentech USA, Inc. | 10 | $170 |
| Lilly USA, LLC | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
Products named: PONVORY, UBRELVY, KESIMPTA, Leqembi, BOTOX, FYCOMPA, Ocrevus Zunovo, Briviact.
Industry payments across KY — which companies pay providers there.
